Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

The Faculty of Medicine - Biochemistry and Molecular Biology: Razin Ehud


 Last updated December 2021 - Biochemistry and Molecular Biology 

List of Publications

(1) Govindaraj S, Paruchuru LB, Razin E. The pLysRS-Ap4A pathway in mast cells regulates the switch from host defense to a pathological state. Int J Mol Sci 2021;22(11).

(2) Rishiq A, Islam O, Golomb E, Gilon D, Smith Y, Savchenko I, et al. The role played by transcription factor e3 in modulating cardiac hypertrophy. Int Heart J 2021;62(6):1358-1368.

(3) Chelombitko MA, Chernyak BV, Fedorov AV, Zinovkin RA, Razin E, Paruchuru LB. Corrigendum: The Role Played by Mitochondria in FcϵRI-Dependent Mast Cell Activation (Frontiers in Immunology, (2020), 11, (584210), 10.3389/fimmu.2020.584210). Front Immunol 2020;11.

(4) Chelombitko MA, Chernyak BV, Fedorov AV, Zinovkin RA, Razin E, Paruchuru LB. The Role Played by Mitochondria in FcεRI-Dependent Mast Cell Activation. Front Immunol 2020;11.

(5) Yu J, Liu Z, Liang Y, Luo F, Zhang J, Tian C, et al. Second messenger Ap4A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells. Nat Commun 2019;10(1).

(6) La Shu S, Paruchuru LB, Tay NQ, Chua YL, Yun Foo AS, Yang CM, et al. Ap4A Regulates Directional Mobility and Antigen Presentation in Dendritic Cells. iScience 2019;16:524-534.

(7) Boulos S, Park MC, Zeibak M, Foo SY, Jeon YK, Kim YT, et al. Erratum: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma (Oncotarget (2017) 8 (65186-65198) DOI:10.18632/oncotarget.18053). Oncotarget 2018;9(90):36250.

(8) Erlich TH, Sharkia I, Landolina N, Assayag M, Goldberger O, Berkman N, et al. Modulation of allergic responses by mitochondrial STAT3 inhibitors. Allergy Eur J Allergy Clin Immunol 2018;73(11):2160-2171.

(9) Motzik A, Amir E, Erlich T, Wang J, Kim B-, Han JM, et al. Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells. Oncogene 2017;36(33):4732-4738.

(10) Sharkia I, Hadad Erlich T, Landolina N, Assayag M, Motzik A, Rachmin I, et al. Pyruvate dehydrogenase has a major role in mast cell function, and its activity is regulated by mitochondrial microphthalmia transcription factor. J Allergy Clin Immunol 2017;140(1):204-214.e8.

(11) Boulos S, Park MC, Zeibak M, Foo SY, Jeon YK, Kim YT, et al. Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma. Oncotarget 2017;8(39):65186-65198.

(12) Wang J, Fang P, Chase P, Tshori S, Razin E, Spicer TP, et al. Development of an HTS-Compatible Assay for Discovery of Melanoma-Related Microphthalmia Transcription Factor Disruptors Using AlphaScreen Technology. J Biomol Screen 2017;22(1):58-66.

(13) Wang J, Fang P, Chase P, Tshori S, Razin E, Spicer TP, et al. Development of an HTS-Compatible Assay for Discovery of Melanoma-Related Microphthalmia Transcription Factor Disruptors Using AlphaScreen Technology. J Biomol Screen 2017;22(1):58-66.

(14) Boulos S, Razin E, Nechushtan H, Rachmin I. Diadenosine Tetraphosphate (Ap4A) in Health and Disease. RNA Technol 2016:207-219.

(15) Rachmin I, Amsalem E, Golomb E, Beeri R, Gilon D, Fang P, et al. FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy. Int J Cardiol 2015;195:85-94.

(16) Cohen-Saidon C, Nechushtan H, Kahlon S, Livni N, Nissim A, Razin E. Errata: A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival (Blood (2003) 102, 7 (2506-2512)). Blood 2015;125(15):2451.

(17) Rachmin I, Tshori S, Smith Y, Oppenheim A, Marchetto S, Kay G, et al. Erbin is a negative modulator of cardiac hypertrophy. Proc Natl Acad Sci U S A 2014;111(16):5902-5907.

(18) Tshori S, Razin E, Nechushtan H. Amino-acyl tRNA synthetases generate dinucleotide polyphosphates as second messengers: functional implications. Top Curr Chem 2014;344:189-206.

(19) Erlich TH, Yagil Z, Kay G, Peretz A, Migalovich-Sheikhet H, Tshori S, et al. Mitochondrial STAT3 plays a major role in IgE-antigen-mediated mast cell exocytosis. J Allergy Clin Immunol 2014;134(2):460-469.e10.

(20) Motzik A, Nechushtan H, Foo SY, Razin E. Non-canonical roles of lysyl-tRNA synthetase in health and disease. Trends Mol Med 2013;19(12):726-731.

(21) Ofir-Birin Y, Fang P, Bennett SP, Zhang H-, Wang J, Rachmin I, et al. Structural Switch of Lysyl-tRNA Synthetase between Translation and Transcription. Mol Cell 2013;49(1):30-42.

(22) Kim DG, Choi JW, Lee JY, Kim H, Oh YS, Lee JW, et al. Interaction of two translational components, lysyl-tRNA synthetase and p40/37LRP, in plasma membrane promotes laminin-dependent cell migration. FASEB J 2012;26(10):4142-4159.

(23) Yagil Z, Hadad Erlich T, Ofir-Birin Y, Tshori S, Kay G, Yekhtin Z, et al. Transcription factor E3, a major regulator of mast cell-mediated allergic response. J Allergy Clin Immunol 2012;129(5):1357-1366.e5.

(24) Carmi-Levy I, Motzik A, Ofir-Birin Y, Yagil Z, Yang CM, Kemeny DM, et al. Importin beta plays an essential role in the regulation of the LysRS-Ap4A pathway in immunologically activated mast cells. Mol Cell Biol 2011;31(10):2111-2121.

(25) Tshori S, Razin E. Editorial: Mast cell degranulation and calcium entry - The Fyn-calcium store connection. J Leukocyte Biol 2010;88(5):837-838.

(26) Yagil Z, Nechushtan H, Kay G, Yang CM, Kemeny DM, Razin E. The enigma of the role of Protein inhibitor of Activated STAT3 (PIAS3) in the immune response. Trends Immunol 2010;31(5):199-204.

(27) Shapira SC, Vinker S, Razin E, Ash N. Military tract of medicine--the need and the vision. Harefuah 2010;149(2):89-90, 124.

(28) Nechushtan H, Kim S, Kay G, Razin E. Chapter 1 The Physiological Role of Lysyl tRNA Synthetase in the Immune System. Adv Immunol 2009;103:1-27.

(29) Yannay-Cohen N, Carmi-Levy I, Kay G, Yang CM, Han JM, Kemeny DM, et al. LysRS Serves as a Key Signaling Molecule in the Immune Response by Regulating Gene Expression. Mol Cell 2009;34(5):603-611.

(30) Yagil Z, Kay G, Nechushtan H, Razin E. A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells. J Immunol 2009;182(4):2168-2175.

(31) Carmi-Levy I, Yannay-Cohen N, Kay G, Razin E, Nechushtan H. Diadenosine tetraphosphate hydrolase is part of the transcriptional regulation network in immunologically activated mast cells. Mol Cell Biol 2008;28(18):5777-5784.

(32) Textor B, Licht AH, Tuckermann JP, Jessberger R, Razin E, Angel P, et al. JunB is required for IgE-mediated degranulation and cytokine release of mast cells. J Immunol 2007;179(10):6873-6880.

(33) Tshori S, Sonnenblick A, Yannay-Cohen N, Kay G, Nechushtan H, Razin E. Microphthalmia transcription factor isoforms in mast cells and the heart. Mol Cell Biol 2007;27(11):3911-3919.

(34) Carmi I, Razin E. The role played by key transcription factors in activated mast cells. Immunol Rev 2007;217(1):280-291.

(35) Jung MH, Min JL, Sang GP, Sun HL, Razin E, Choi E-, et al. Hierarchical network between the components of the multi-tRNA synthetase complex: Implications for complex formation. J Biol Chem 2006;281(50):38663-38667.

(36) Tshori S, Gilon D, Beeri R, Nechushtan H, Kaluzhny D, Pikarsky E, et al. Transcription factor MITF regulates cardiac growth and hypertrophy. J Clin Invest 2006;116(10):2673-2681.

(37) Yannay-Cohen N, Razin E. Translation and transcription: The dual functionality of LysRS in mast cells. Mol Cells 2006;22(2):127-132.

(38) Levy C, Lee Y-, Nechushtan H, Schueler-Furman O, Sonnenblick A, Hacohen S, et al. Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3. Blood 2006;107(7):2839-2845.

(39) Cohen-Saidon C, Carmi I, Keren A, Razin E. Antiapoptotic function of Bcl-2 in mast cells is dependent on its association with heat shock protein 90β. Blood 2006;107(4):1413-1420.

(40) Nechushtan H, Razin E. Mast cells: Must they always be different? Blood 2006;107(1):1-2.

(41) MacGlashan D, Galli SJ, Austen KF, Pecht I, Kawakami T, Brown M, et al. Discussion. Novartia Found Symp 2005;271:89-94.

(42) Stevens R, Kitamura Y, Koyasu S, Rao A, Galli SJ, Ono SJ, et al. Discussion. Novartia Found Symp 2005;271:11-14.

(43) Metcalfe DD, Oettgen H, Metzger H, Marshall JS, Rivera J, Galli SJ, et al. Discussion. Novartia Found Symp 2005;271:24-38.

(44) Pecht I, Razin E, Metcalfe DD, Koyasu S, Rivera J, Walls A, et al. Discussion. Novartia Found Symp 2005;271:195-197.

(45) Austen KF, Galli SJ, Rivera J, Oettgen H, Brown M, Koffer A, et al. Discussion. Novartia Found Symp 2005;271:124-130.

(46) Ono SJ, Stevens R, Razin E, Kitamura Y, Austen KF, Rivera J, et al. General discussion I. Novartia Found Symp 2005;271:95-99.

(47) Rivera J, Stevens R, Metcalfe DD, Razin E, Rao A, Ono SJ, et al. Discussion. Novartia Found Symp 2005;271:68-77.

(48) Koffer A, Rivera J, Stevens R, Razin E, MacGlashan D, Koyasu S, et al. Discussion. Novartia Found Symp 2005;271:47-53.

(49) Razin E, Monticelli S, Rao A, Rivera J, Stevens R, Brown M, et al. Discussion. Novartia Found Symp 2005;271:187-190.

(50) Razin E, Austen KF, Rivera J, Marshall JS, Koyasu S, Metcalfe DD, et al. Discussion. Novartia Found Symp 2005;271:176-178.

(51) Pecht I, Kawakami T, Rivera J, Stevens R, MacDonald SM, Koyasu S, et al. Discussion. Novartia Found Symp 2005;271:108-114.

(52) Cohen-Saidon C, Razin E. The involvement of Bcl-2 in mast cell apoptosis. Novartia Found Symp 2005;271:191-195.

(53) Lee Y-, Razin E. Nonconventional involvement of LysRS in the molecular mechanism of USF2 transcriptional activity in FcεRI-activated mast cells. Mol Cell Biol 2005;25(20):8904-8912.

(54) Sonnenblick A, Levy C, Razin E. Immunological trigger of mast cells by monomeric IgE: Effect on microphthalmia transcription factor, STAT3 network of interactions. J Immunol 2005;175(3):1450-1455.

(55) Miller AJ, Levy C, Davis IJ, Razin E, Fisher DE. Sumoylation of MITF and its related family members TFE3 and TFEB. J Biol Chem 2005;280(1):146-155.

(56) Sonnenblick A, Levy C, Razin E. Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes. Mol Cell Biol 2004;24(24):10584-10592.

(57) Lee Y-, Tuckerman J, Nechushtan H, Schutz G, Razin E, Angel P. c-Fos as a regulator of degranulation and cytokine production in FcεRI-activated mast cells. J Immunol 2004;173(4):2571-2577.

(58) Lee Y-, Nechushtan H, Figov N, Razin E. The Function of Lysyl-tRNA Synthetase and Ap4A as Signaling Regulators of MITF Activity in FcεRI-Activated Mast Cells. Immunity 2004;20(2):145-151.

(59) Levy C, Sonnenblick A, Razin E. Role Played by Microphthalmia Transcription Factor Phosphorylation and Its Zip Domain in Its Transcriptional Inhibition by PIAS3. Mol Cell Biol 2003;23(24):9073-9080.

(60) Cohen-Saidon C, Nechushtan H, Kahlon S, Livni N, Nissim A, Razin E. A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival. Blood 2003;102(7):2506-2512.

(61) Nechushtan H, Razin E. The function of MITF and associated proteins in mast cells. Mol Immunol 2002;38(16-18):1177-1180.

(62) Levy C, Nechushtan H, Razin E. A new role for the STAT3 inhibitor, PIAS3: A repressor of microphthalmia transcription factor. J Biol Chem 2002;277(3):1962-1966.

(63) Nechushtan H, Razin E. Studies of different aspects of the role of protein kinase C in mast cells. Int Arch Allergy Immunol 2001;124(1-3):130-132.

(64) Nechushtan H, Leitges M, Cohen C, Kay G, Razin E. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood 2000;95(5):1752-1757.

(65) Bauer O, Razin E. Mast cell-nerve interactions. News Physiol Sci 2000;15(5):213-218.

(66) Razin E, Zhang ZC, Nechushtan H, Frenkel S, Lee Y-, Arudchandran R, et al. Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J Biol Chem 1999;274(48):34272-34276.

(67) Frenkel S, Kay G, Nechushtan H, Razin E. Nuclear translocation of upstream stimulating factor 2 (USF2) in activated mast cells: A possible role in their survival. J Immunol 1998;161(6):2881-2887.

(68) Zhang ZC, Nechushtan H, Jacob-Hirsch J, Avni D, Meyuhas O, Razin E. Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells. Oncogene 1998;16(6):763-769.

(69) Nechushtan H, Razin E. Deciphering the early-response transcription factor networks in mast cells. Immunol Today 1998;19(10):441-444.

(70) Ligumsky M, Kuperstein V, Nechushtan H, Zhang Z, Razin E. Analysis of cytokine profile in human colonic mucosal FcεRI-positive cells by single cell PCR: Inhibition of IL-3 expression in steroid-treated IBD patients. FEBS Lett 1997;413(3):436-440.

(71) Nechushtan H, Zhang Z, Razin E. Microphthalmia (mi) in murine mast cells: Regulation of its stimuli- mediated expression on the translational level. Blood 1997;89(8):2999-3008.

(72) Razin E, Lewin I, Zang Z-, Kupershtein V, Jacob-Hirsch J, Nechushtan H, et al. Translational regulation of mast cell USF-2 (fos-interacting protein) synthesis by cytokines and IgE-Ag: The dependency on PKC-β. FASEB J 1996;10(6).

(73) Necbushtan H, Soreq H, Kuperstein V, Tshoritf S, Razin E. Murine and human mast cells express acetylcholinesterase. FASEB J 1996;10(6).

(74) Nechushtan H, Soreq H, Kuperstein V, Tshori S, Razin E. Murine and human mast cell express acetylcholinesterase. FEBS Lett 1996;379(1):1-6.

(75) Lewin I, Jacob-Hirsch J, Zang ZC, Kupershtein V, Szallasi Z, Rivera J, et al. Aggregation of the FcεRI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding activity: The dependence on protein kinase C-β. J Biol Chem 1996;271(3):1514-1519.

(76) Nechushtan H, Razin E. Regulation of mast cell growth and proliferation. CRIT REV ONCOL HEMATOL 1996;23(2):131-150.

(77) Chaikin E, Hakeem I, Razin E. The incapability of lnterleukin-4 to induce AP-1 activity in murine mast cells. Int Arch Allergy Immunol 1995;107(1-3):57-59.

(78) Cruz JR, Cano F, Razin E, Acheson DWK, Keusch GT. Fecal excretion of leukotriene C4 during human disease due to shigella dysenteriae. J Pediatr Gastroenterol Nutr 1995;20(2):179-183.

(79) Razin E, Pecht I, Rivera J. Signal transduction in the activation of mast cells and basophils. Immunol Today 1995;16(8):370-373.

(80) Razin E, Szallasi Z, Kazanietz MG, Blumberg PM, Rivera J. Protein kinases C-β and C-ε link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun. Proc Natl Acad Sci U S A 1994;91(16):7722-7726.

(81) Chaikin E, Hakeem I, Razin E. Enhancement of interleukin-3-dependent mast cell proliferation by suppression of c-jun expression. J Biol Chem 1994;269(11):8498-8503.

(82) Ophir A, Berenshtein E, Ziltener HJ, Razin E. 5-Fluorouracil and mast cell precursors in mice. Exp Hematol 1993;21(12):1558-1562.

(83) Baranes D, Lewin I, Razin E. Serum modulates mast cell responses to IgE antigen stimulation. Eur J Immunol 1993;23(1):291-294.

(84) Lewin I, Nechushtan H, Ke Q, Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: The role played by protein kinase C and the possible involvement of Fos interacting protein. Blood 1993;82(12):3745-3751.

(85) Razin E, Leslie KB, Schrader JW. Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction. J Immunol 1991;146(3):981-987.

(86) Baranes D, Razin E. Protein kinase C regulates proliferation of mast cells and the expression of the mRNAs of fos and jun proto-oncogenes during activation by IgE-Ag or calcium ionophore A23187. Blood 1991;78(9):2354-2364.

(87) Chaikin E, Ziltener HJ, Razin E. Protein kinase C plays an inhibitory role in interleukin 3- and interleukin 4-mediated mast cell proliferation. J Biol Chem 1990;265(36):22109-22116.

(88) Davidson S, Gilead L, Amira M, Ginsburg H, Razin E. Synthesis of chondroitin sulfate D and heparin proteoglycans in murine lymph node-derived mast cells. The dependence on fibroblasts. J Biol Chem 1990;265(21):12324-12330.

(89) Bashkin P, Razin E, Eldor A, Vlodavsky I. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood 1990;75(11):2204-2212.

(90) Gilead L, Bibi O, Razin E. Fibroblasts induce heparin synthesis in chondroitin sulfate E containing human bone marrow-derived mast cells. Blood 1990;76(6):1188-1195.

(91) Razin E. Culture of bone marrow-derived mast cells: A model for studying oxidative metabolism of arachidonic acid and synthesis of other molecules derived from membrane phospholipids. Methods Enzymol 1990;187(C):514-520.

(92) Matzner Y, Cohn M, Hyam E, Razin E, Fuks Z, Buchanan MR, et al. Generation of lipid neutrophil chemoattractant by irradiated bovine aortic endothelial cells. J Immunol 1988;140(8):2681-2685.

(93) Gilead L, Rahamim E, Ziv I, Or R, Razin E. Cultured human bone marrow-derived mast cells, their similarities to cultured murine E-mast cells. Immunology 1988;63(4):669-675.

(94) Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 1988;95(5):1167-1172.

(95) Gilead L, Livni N, Eliakim R, Ligumsky M, Fich A, Okon E, et al. Human gastric mucosal mast cells are chondroitin sulphate E-containing mast cells. Immunology 1987;62(1):23-28.

(96) Lerner M, Samuni A, Razin E. Stimulation of murine cultured mast cells under anaerobic conditions: inhibition of arachidonic acid release. Immunol Lett 1987;16(2):121-124.

(97) Baranes D, Matzner J, Razin E. Thrombin-induced calcium-independent degranulation of human neutrophils. Inflammation 1986;10(4):455-461.

(98) Razin E, Baranes D. Thrombin-induced lysozyme release from human neutrophils and phosphatidylinositol breakdown in cultured mouse E mast cells. Adv Prostaglandin Thromboxane Leukot Res 1986;16:135-140.

(99) Baranes D, Liu FT, Razin E. Thrombin and IgE antigen induce formation of inositol phosphates by mouse E-mast cells. FEBS Lett 1986;206(1):64-68.

(100) Shalit M, Shoam H, Seno N, Razin E. New role for heparan sulfate: Regulator of leukotriene generation in mouse E-mast cells. Life Sci 1986;39(10):903-910.

(101) Eliakim R, Gilead L, Ligumsky M, Okon E, Rachmilewitz D, Razin E. Histamine and chondroitin sulfate E proteoglycan released by cultured human cell colonic mucosa: Indication for possible presence of E mast cells. Proc Natl Acad Sci U S A 1986;83(2):461-464.

(102) Baranes D, Liu F-, Marx G, Shalit M, Razin E. Regulation of thrombin-induced mast cell degranulation by zinc and manganese. Immunol Lett 1986;12(2-3):95-99.

(103) Pervin R, Kanner BI, Marx G, Razin E. Thrombin-induced degranulation of cultured bone marrow-derived mast cells: Effect on calcium uptake. Immunology 1985;56(4):667-672.

(104) Shoam H, Razin E. BW755C inhibits the 5-lipoxygenase in E-mast cells without affecting degranulation. Biochim Biophys Acta Lipids Lipid Metab 1985;837(1):1-5.

(105) Razin E, Baranes D, Marx G. Thrombin-Mast cell interactions. Binding and cell activation. Exp Cell Res 1985;160(2):380-386.

(106) Marx G, Barnes D, Razin E. Thrombin selective activation of mast cells. Fed Proc 1985;44(4).

(107) Razin E. Activation of the 5-lipoxygenase pathway in E-mast cells by peanut agglutinin. J Immunol 1985;134(2):1142-1145.

(108) Stevens RL, Bloes WF, Seldin DC, Razin E, Katz HR, Austen KF. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype. J Immunol 1984;133(5):2674-2680.

(109) Razin E, Marx G. Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J Immunol 1984;133(6):3282-3285.

(110) Razin E, Romeo LC, Krilis S, Liu FT, Lewis RA, Corey EJ, et al. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells. J Immunol 1984;133(2):938-945.

(111) Razin E, Stevens RL, Austen KF, Caulfield JP, Hein A, Liu FT, et al. Cloned mouse mast cells derived from immunized lymph node cells and from foetal liver cells exhibit characteristics of bone marrow-derived mast cells containing chondroitin sulphate E proteoglycan. Immunology 1984;52(3):563-575.

(112) Razin E, Ihle JN, Seldin D, Mencia-Huerta JM, Katz HR, LeBlanc PA, et al. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 1984;132(3):1479-1486.

(113) Razin E, Lewis RA, Corey EJ, Austen KF. Separation of 5-lipoxygenase product generation and secretion of preformed mediators from mouse bone marrow-derived mast cells (BMMC). Fed Proc 1984;43(6).

(114) Mencia Huerta JM, Lewis RA, Razin E, Austen KF. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. J Immunol 1983;131(6):2958-2964.

(115) Stevens RL, Razin E, Austen KF, Hein A, Caulfield JP, Seno N, et al. Synthesis of chondroitin sulfate E glycosaminoglycan onto p-nitrophenyl-β-D-xyloside and its localization to the secretory granules of rat serosal mast cells and mouse bone marrow-derived mast cells. J Biol Chem 1983;258(9):5977-5984.

(116) Mencia-Huerta JM, Razin E, Ringel EW, Corey EJ, Hoover D, Austen KF, et al. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. J Immunol 1983;130(4):1885-1890.

(117) Razin E, Mencia-Huerta J-, Stevens RL, Lewis RA, Liu F-, Corey EJ, et al. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, β-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med 1983;157(1):189-201.

(118) Razin E, Stevens RL, Akiyama F, Schmid K, Austen KF. Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate. J Biol Chem 1982;257(12):7229-7236.

(119) Razin E, Mencia-Huerta JM, Lewis RA, Corey EJ, Austen KF. Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. Proc Natl Acad Sci U S A 1982;79(15):4665-4667.

(120) Razin E, Cordon-Cardo A, Minick CR, Good RA. Studies on the exocytosis of cultured mast cells derived from mouse bone marrow. Exp Hematol 1982;10(6):524-532.

(121) Razin E, Rifkind AB, Cordon-Cardo C, Good RA. Selective growth of a population of human basophil cells in vitro. Proc Natl Acad Sci U S A 1981;78(9 II):5793-5796.

(122) Razin E, Cordon-Cardo C, Good RA. Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A 1981;78(4 II):2559-2561.